Annual ROE
137.79%
+640.59%+127.40%
01 December 2023
Summary:
NLS Pharmaceutics AG annual return on equity is currently 137.79%, with the most recent change of +640.59% (+127.40%) on 01 December 2023. During the last 3 years, it has risen by +105.94% (+332.62%). NLSP annual ROE is now at all-time high.NLSP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLSP ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +127.4% | - |
| 3 y3 years | +332.6% | - |
| 5 y5 years | +135.9% | - |
NLSP ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +106.3% | ||
| 5 y | 5 years | at high | +106.3% | ||
| alltime | all time | at high | +106.3% |
NLS Pharmaceutics AG ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | 137.79%(-127.4%) | - |
| Dec 2022 | -502.80%(-77.2%) | - |
| Dec 2021 | -2202.45%(-7015.1%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | 31.85%(-63.9%) | - |
| Dec 2019 | 88.27%(+51.1%) | - |
| Dec 2018 | 58.40%(-32.3%) | - |
| Dec 2017 | 86.26% | - |
FAQ
- What is NLS Pharmaceutics AG annual return on equity?
- What is the all time high annual ROE for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual ROE year-on-year change?
What is NLS Pharmaceutics AG annual return on equity?
The current annual ROE of NLSP is 137.79%
What is the all time high annual ROE for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual return on equity is 137.79%
What is NLS Pharmaceutics AG annual ROE year-on-year change?
Over the past year, NLSP annual return on equity has changed by +640.59% (+127.40%)